eF-site ID 5cba-ABCDEF PDB Code 5cba Chain A, B, C, D, E, F click to enlarge Title 3B4 in complex with CXCL13 - 3B4-CXCL13 Classification IMMUNE SYSTEM Compound 3b4 heavy chain Source (CXL13_HUMAN) Sequence A:  QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQA PGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAY MELSSLRSEDTAVYYCAREPDYYDSSGYYPIDAFDIWGQG TTVTVSS B:  QSALTQPASVSASPGQSITISCTGTSSDVGAYDWVSWYQQ HPGKAPKLLIFDVNNRPSGVSHRFSGSKSGNTASLTISGL QAEDEADYYCSSYTRRDTYVFGTGTKVTVLGE C:  QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQA PGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAY MELSSLRSEDTAVYYCAREPDYYDSSGYYPIDAFDIWGQG TTVTVSS D:  QSALTQPASVSASPGQSITISCTGTSSDVGAYDWVSWYQQ HPGKAPKLLIFDVNNRPSGVSHRFSGSKSGNTASLTISGL QAEDEADYYCSSYTRRDTYVFGTGTKVTVLG E:  RCRCVQESSVFIPRRFIDRIQILPRGNGCPRKEIIVWKKN KSIVCVDPQAEWIQRMMEVLR F:  SLRCRCVQESSVFIPRRFIDRIQILPRGNGCPRKEIIVWK KNKSIVCVDPQAEWIQRMMEVLRK Description Functional site 1) chain A residue 95 type sequence E description binding site for residue EDO A 201 source : AC1 2) chain A residue 100 type sequence D description binding site for residue EDO A 201 source : AC1 3) chain B residue 91 type sequence Y description binding site for residue EDO A 201 source : AC1 4) chain E residue 21 type sequence R description binding site for residue EDO A 201 source : AC1 5) chain E residue 22 type sequence R description binding site for residue EDO A 201 source : AC1 6) chain A residue 7 type sequence S description binding site for residue PEG A 202 source : AC2 7) chain A residue 8 type sequence G description binding site for residue PEG A 202 source : AC2 8) chain A residue 9 type sequence A description binding site for residue PEG A 202 source : AC2 9) chain A residue 105 type sequence Q description binding site for residue PEG A 202 source : AC2 10) chain A residue 106 type sequence G description binding site for residue PEG A 202 source : AC2 11) chain A residue 107 type sequence T description binding site for residue PEG A 202 source : AC2 12) chain A residue 108 type sequence T description binding site for residue PEG A 202 source : AC2 13) chain A residue 100 type sequence D description binding site for residue EDO B 201 source : AC3 14) chain B residue 30 type sequence Y description binding site for residue EDO B 201 source : AC3 15) chain B residue 31 type sequence D description binding site for residue EDO B 201 source : AC3 16) chain B residue 50 type sequence D description binding site for residue EDO B 201 source : AC3 17) chain F residue 6 type sequence S description binding site for residue EDO B 201 source : AC3 18) chain C residue 95 type sequence E description binding site for residue EDO C 201 source : AC4 19) chain C residue 100 type sequence D description binding site for residue EDO C 201 source : AC4 20) chain D residue 91 type sequence Y description binding site for residue EDO C 201 source : AC4 21) chain F residue 22 type sequence R description binding site for residue EDO C 201 source : AC4 22) chain E residue 13 type sequence Q description binding site for residue EDO E 101 source : AC5 23) chain E residue 15 type sequence S description binding site for residue EDO E 101 source : AC5 24) chain E residue 51 type sequence V description binding site for residue EDO E 101 source : AC5 25) chain E residue 52 type sequence C description binding site for residue EDO E 101 source : AC5 26) chain B residue 21 type MOD_RES sequence I description Pyrrolidone carboxylic acid => ECO:0000269|PubMed:500108 source Swiss-Prot : SWS_FT_FI1 27) chain D residue 21 type MOD_RES sequence I description Pyrrolidone carboxylic acid => ECO:0000269|PubMed:500108 source Swiss-Prot : SWS_FT_FI1 28) chain E residue 9-54 type prosite sequence CRCVQESSVFIPRRFIDRIQILPRGNGCPRKEIIVWKKNK SIVCVD description SMALL_CYTOKINES_CXC Small cytokines (intercrine/chemokine) C-x-C subfamily signature. CrCVqessvfIprRfIdrIqilprGngCprkEIIvwkknksiv.CVD source prosite : PS00471

Display surface Download Links